ReviewBritish journal of clinical pharmacology2003
Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality.
Review in British journal of clinical pharmacology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 1 synthesis or guideline pooled it, 171 citations in OpenAlex.
- Aromatherapy for dementia.The Cochrane database of systematic reviews · 2020Pooled it
- Integrative approaches in Alzheimer's disease: evaluating the potential of traditional, complementary, and integrative medicine (TCIM).Frontiers in pharmacology · 2025Review
- Coal-Derived Humic Substances: Insight into Chemical Structure Parameters and Biomedical Properties.Molecules (Basel, Switzerland) · 2024Article
- Consumption and adverse reaction reporting of herbal medicines among people living with HIV at University teaching hospitals in Blantyre, Malawi and Ibadan, Nigeria.Malawi medical journal : the journal of Medical Association of Malawi · 2024Article
- Self-Completion Questionnaire on Sleep Evaluation in Patients Undergoing Oxaliplatin Therapy: An Observational Study.Cancers · 2024Article
- Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance.Cancer chemotherapy and pharmacology · 2023Review
- Public knowledge, attitudes, and practices towards herbal medicines; a cross-sectional study in Western Saudi Arabia.BMC complementary medicine and therapies · 2022Article
- Metabolite Fingerprinting Based onMolecules (Basel, Switzerland) · 2022Review
- The Future of Medicine: Frontiers in Integrative Health and Medicine.Medicina (Kaunas, Lithuania) · 2021Article
- The Role of Botanical Families in Medicinal Ethnobotany: A Phylogenetic Perspective.Plants (Basel, Switzerland) · 2021Article
- Anti-Antibiotics (Basel, Switzerland) · 2020Review
- Active Ingredients and Mechanism of Action of Rhizoma Coptidis against Type 2 Diabetes Based on Network-Pharmacology and Bioinformatics.Current medical science · 2020Article
- Chemical Composition, Antimicrobial activity, in Vitro Cytotoxicity and Leukotoxin Neutralization of Essential Oil fromPathogens (Basel, Switzerland) · 2020Article
- An unusual presentation of chronic cyanide toxicity from self-prescribed apricot kernel extract.BMJ case reports · 2017Article
- Community pharmacists' perceptions about pharmaceutical service of over-the-counter traditional Chinese medicine: a survey study in Harbin of China.BMC complementary and alternative medicine · 2017Article
- Cytotoxicity Evaluation of Essential Oil and its Component from Zingiber officinale Roscoe.Toxicological research · 2016Article
- Use of Moringa oleifera Flower Pod Extract as Natural Preservative and Development of SCAR Marker for Its DNA Based Identification.BioMed research international · 2016Article
- Why is Research on Herbal Medicinal Products Important and How Can We Improve Its Quality?Journal of traditional and complementary medicine · 2014Article
- Concomitant intake of quercetin with a grain-based diet acutely lowers postprandial plasma glucose and lipid concentrations in pigs.BioMed research international · 2014Article
- Consumers' attitude towards the use and safety of herbal medicines and herbal dietary supplements in Serbia.International journal of clinical pharmacy · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is the first of two papers which review issues concerning complementary medicines. The first reviews the extent of use of complementary medicines, and issues related to the regulation and pharmaceutical quality of these products; the second considers evidence for the efficacy of several well-known complementary medicines, and discusses complementary-medicines pharmacovigilance. The term complementary medicines describes a range of pharmaceutical-type preparations, including herbal medicines, homoeopathic remedies, essential oils and dietary supplements, which mainly sit outside conventional medicine. The use of complementary medicines is a popular healthcare approach in the UK, and there are signs that the use of such products is continuing to increase. Patients and the public use complementary medicines for health maintenance, for the treatment or prevention of minor ailments, and also for serious, chronic illnesses. The pervasive use of complementary medicines raises several concerns. Many of these arise because most complementary medicines are not licensed as medicines, and therefore evidence of quality, efficacy and safety is not required before marketing. The regulatory framework for herbal medicines and dietary supplements is currently under review. A new system for registration of traditional herbal medicines will ensure that marketed products meet standards for quality and safety. At present, the pharmaceutical quality of many complementary medicines is a cause for concern.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.